You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR VIDAZA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Vidaza

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00101179 ↗ MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Completed National Cancer Institute (NCI) Phase 1 2004-11-03 MS-275 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving MS-275 together with azacitidine may kill more cancer cells. This phase I trial is studying the side effects and best dose of MS-275 when given together with azacitidine in treating patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia.
NCT00118287 ↗ Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes Completed National Cancer Institute (NCI) Phase 1/Phase 2 2005-04-01 This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azacitidine, works in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as etanercept, may protect normal cells from the side effects of chemotherapy
NCT00118287 ↗ Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes Completed Fred Hutchinson Cancer Research Center Phase 1/Phase 2 2005-04-01 This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azacitidine, works in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as etanercept, may protect normal cells from the side effects of chemotherapy
NCT00118287 ↗ Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes Completed Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Phase 1/Phase 2 2005-04-01 This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azacitidine, works in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as etanercept, may protect normal cells from the side effects of chemotherapy
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vidaza

Condition Name

Condition Name for Vidaza
Intervention Trials
Acute Myeloid Leukemia 65
Myelodysplastic Syndrome 54
Leukemia 33
Myelodysplastic Syndromes 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Vidaza
Intervention Trials
Leukemia 139
Myelodysplastic Syndromes 133
Preleukemia 124
Leukemia, Myeloid, Acute 122
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Vidaza

Trials by Country

Trials by Country for Vidaza
Location Trials
United States 790
Canada 41
France 39
Germany 35
Australia 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Vidaza
Location Trials
Texas 102
California 46
New York 44
Ohio 39
Illinois 37
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Vidaza

Clinical Trial Phase

Clinical Trial Phase for Vidaza
Clinical Trial Phase Trials
Phase 4 1
Phase 3 8
Phase 2/Phase 3 2
[disabled in preview] 104
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Vidaza
Clinical Trial Phase Trials
Completed 94
Recruiting 49
Terminated 40
[disabled in preview] 30
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Vidaza

Sponsor Name

Sponsor Name for Vidaza
Sponsor Trials
National Cancer Institute (NCI) 77
M.D. Anderson Cancer Center 54
Celgene Corporation 46
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Vidaza
Sponsor Trials
Other 200
Industry 185
NIH 77
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.